InvestorsHub Logo
Followers 396
Posts 17865
Boards Moderated 1
Alias Born 06/07/2018

Re: None

Thursday, 11/12/2020 3:15:50 AM

Thursday, November 12, 2020 3:15:50 AM

Post# of 159
$SVAP Standard Vape Corp Announces Joint Venture
Press Release | 11/10/2020
Standard Vape (AP) Announces Joint Venture "Life Wellness JV" to Develop Line of PPE Equipment Using Nitric Oxide Dry Powder NanoNOx



LOCUST VALLEY, NY / ACCESSWIRE / November 10, 2020 /Standard Vape Corporation (OTC PINK:SVAP) announced today that its wholly owned subsidiary Neo-Virucide, Inc. (NVI) (www.neovirucide.com) the Licensee of the NanoNOx technology from NMB Therapeutics,Inc.(NMB)(www.nmbtherapeutics.com) ,signed a Joint Venture (JV) agreement with Vivian Li Kremer to create new and improved forms of PPE using the services of NVI scientific team. As part of the agreement Life Wellness JV has and will provide the scientific team with expanded laboratory space in exchange for 51% of any revenue generated by the JV from sales of the resulting PPE to hospitals or medical facilities should such sales occur.



The NanoNOxTMcompound developed by NMB and licensed for worldwide distribution to NVI, the SVAP subsidiary, uses Nano technology to encapsulate Nitric Oxide in a dry powder form that can be inhaled through a conventional inhaler, which will then have a controlled release of nitric oxide deep inside the lungs upon contact. The Company believes that this approach can be applied to PPE equipment such as masks and gowns.



Scientific papers regarding the use of Nano particles and previous studies are available atwww.neovirucide.com.



Legal Disclaimer

This release contains forward-looking statements within the meaning of Section 27a of the Securities Act of 1933, as amended and section 21e of the Securities and Exchange Act of 1934, as amended. Those statements include the intent, belief or current expectations of the company and its management team. Forward-looking statements are projections of events, revenues, income, future economics, research, development, reformulation, product performance or management's plans and objectives for future operations. Some or all the events or results anticipated by these forward-looking statements may not occur. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those projected in the forward-looking statements as a result of various factors. Accomplishing the strategy described herein is significantly dependent upon numerous factors, many that are not in management's control.

Contact Information:

Roger Fidler
NVI President
(201) 220-8734
rfidler0099@aol.com

Brinsley Holman
+44 (0)207 464 4090
brinsley.holman@kbrl.co.uk.

SOURCE:Standard Vape Corp.

Hi my posts are for entertainment purposes only. Consult a professional. And if it lasts longer than 4 hours, call a physician with a good camera.